Explain the respective product roles, combination development logic, stability, and label expression of digestive enzymes and probiotics, avoiding mere accumulation of ingredients.

Discuss the development of palatability from aspects such as protein flavor, powder texture, aroma, solubility, and single-bag specifications, and explain the importance of sample testing.

Focusing on the manufacturing stability, strain identification, compounding, and labeling considerations of spore-forming probiotics, targeting brands that prioritize shelf life.

Introduce the product logic of Biostime, common types of prebiotics, differences between dogs and cats, and suitable powder/tablet forms, providing ideas for combination formulas.

Discuss the impact of temperature, moisture, oxygen, packaging barrier properties, and storage conditions on the stability of pet probiotics, highlighting the synergy between manufacturing and packaging.

Explain the difference between the number of live bacteria during production and the guaranteed value at the end of shelf life, and advise buyers to verify which data to check in the specification, COA, and packaging label.

Explain the development framework of multi-strain products from aspects such as target species, strain combination, indicated viable cell count, prebiotics, flavor, and moisture control.

Compare the differences between powder, tablet, and capsule formulations in terms of feeding methods, activity protection, packaging, cost, and target channels, to provide a basis for formulation selection.

From the perspective of brand development, compare the stability, label expression, consumer cognition, and combination methods of three types of enteral nutrition concepts to avoid confusing different concepts.

Examine the significance of common microbial categories and information on different strains in pet probiotics, as well as the items that brand owners should confirm with the factory regarding formulas and labels.

Explain to brand owners about strains, CFU, prebiotics, digestive enzymes, storage conditions, and shelf life labeling, and connect probiotic powders, capsules, and tablets.

Provide a pre-inquiry checklist covering target market, species, efficacy direction, dosage form, specification, quantity, packaging, and compliance requirements to enhance communication efficiency between both parties.

Explain the time required for demand confirmation, sample preparation, packaging, label review, production, and transportation through two paths: ready-made formulas and customized formulas, to reduce misunderstandings about delivery time.

Explain the suitable raw material types, loading capacity, fluidity, moisture resistance, and bottling requirements for hard capsules, and discuss lactoferrin, probiotics, and heart-protecting capsules.

Explain the uniformity of mixing, flowability, hygroscopicity, flavor, packaging options (bagging or canning), and connection to existing powder products for pet feed.

Highlight the advantages of tablet dosage forms in terms of precise dosing, stable production, and cost control, and list the tablet compression, coating, testing, and packaging capabilities that buyers should verify.

Compare the differences between customized formulations and mature off-the-shelf formulations in terms of development cycle, uniqueness, cost, testing, and time-to-market to help buyers determine project strategies.

Focusing on hairball control, probiotics, urinary health, and taurine as core components, the feline product line highlights functional layering, dosage form selection, and palatability priorities.